NEW DEAL: Patient Access

Published: Thu, 12/05/19

NEW DEAL: Patient Access

Dear Member,

Following the recent PharmaPlus November 2019 seminars we are pleased to announce our NEW deal with Patient Access.

Patient Access App & Patient.info have existed for well over 10 years now and owned by EMIS Group for almost 10 years.

Patient Platform Limited created by EMIS Health in 2016 to give a more patient central focus to Patient.info and the Patient Access App.

Now untethered – will link with any GP system from Jan 2020 – not only EMIS Web.

Please find the following attachments with this email:

1) Pharma Plus members deal sheet - giving detailed information about Patient Access and our deal with them.

2) Patient Access order form.

3) Direct Debit instruction mandate.

PharmaPlus

SPECIAL OFFER

As a special introductory offer, the first 30 members that sign up with Patient Access before 31 December 2019 will benefit with 3 months free* (January, February & March 2020) on the Patient Access £50 monthly subscription fee (Total £150).

*This PharmaPlus subsidy will be in the form of a credit note against our annual membership fee April 2020 – March 2021.

Please note members will need to sign up to a Stripe Connect Account; one form of ID will be required to be scanned & sent with the order form (either Passport or Driving Licence)– attached with the order form.

If you require any further information please contact us at PharmaPlus office on 02088633335

Regards,

PharmaPlus

Book Your TRAINING

Pre-Reg Training 2019

Pharma Plus Ltd.

Unit B1-B3, Livingstone Court, 55 Peel Road, Harrow, Middlesex HA37QT

info@pharmaplusltd.co.uk | Tel: 020 8863 3335 | Fax: 020 8863 4144 | www.pharmaplusltd.co.uk

Missed an email? Click here for an archive of our most recent communications!

NOTICE

The information contained in this electronic transmission is protected by privilege (which is not waived), strictly confidential and intended for use only by the addressee. If you receive this electronic transmission by mistake then the dissemination distribution or copying of it is strictly prohibited. In such a case please contact us immediately by telephone or return this electronic transmission.